50158 Federal Register / Vol. 82, No. 208 / Monday, October 30, 2017 / Notices 

1Handbook for Electronic Filing Procedures: 

https://www.usitc.gov/documents/handbook_on_

filing_procedures.pdf. 

2All contract personnel will sign appropriate 

nondisclosure agreements. 

3Electronic Document Information System 

(EDIS): https://edis.usitc.gov. 

calendar days after the date of 

publication of this notice in the Federal 

Register. There will be further 

opportunities for comment on the 

public interest after the issuance of any 

final initial determination in this 

investigation. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above and submit 8 true paper 

copies to the Office of the Secretary by 

noon the next day pursuant to § 210.4(f) 

of the Commission’s Rules of Practice 

and Procedure (19 CFR 210.4(f)). 

Submissions should refer to the docket 

number (‘‘Docket No. 3268’’) in a 

prominent place on the cover page and/ 

or the first page. (See Handbook for 

Electronic Filing Procedures, Electronic 

Filing Procedures 1). Persons with 

questions regarding filing should 

contact the Secretary (202–205–2000). 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All such requests 

should be directed to the Secretary to 

the Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel,2 solely for cybersecurity 

purposes. All nonconfidential written 

submissions will be available for public 

inspection at the Office of the Secretary 

and on EDIS.3

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of §§ 201.10 and 210.8(c) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.8(c)). 

By order of the Commission. 

Issued: October 25, 2017. 

Lisa R. Barton, 

Secretary to the Commission. 

[FR Doc. 2017–23543 Filed 10–27–17; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1079] 

Certain Shaving Cartridges, 

Components Thereof and Products 

Containing Same Institution of 

Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that a 

complaint was filed with the U.S. 

International Trade Commission on 

September 25, 2017, under section 337 

of the Tariff Act of 1930, as amended, 

on behalf of The Gillette Company LLC 

of Boston, Massachusetts. A supplement 

to the complaint was filed on September 

28, 2017. The complaint, as 

supplemented, alleges violations of 

section 337 based upon the importation 

into the United States, the sale for 

importation, and the sale within the 

United States after importation of 

certain shaving cartridges, components 

thereof and products containing same 

by reason of infringement of U.S. Patent 

No. 9,193,077 (‘‘the ’077 patent’’). The 

complaint further alleges that an 

industry in the United States exists as 

required by the applicable Federal 

Statute. 

The complainant requests that the 

Commission institute an investigation 

and, after the investigation, issue a 

limited exclusion order and cease and 

desist orders. 

ADDRESSES: The complaint, except for 

any confidential information contained 

therein, is available for inspection 

during official business hours (8:45 a.m. 

to 5:15 p.m.) in the Office of the 

Secretary, U.S. International Trade 

Commission, 500 E Street SW., Room 

112, Washington, DC 20436, telephone 

(202) 205–2000. Hearing impaired 

individuals are advised that information 

on this matter can be obtained by 

contacting the Commission’s TDD 

terminal on (202) 205–1810. Persons 

with mobility impairments who will 

need special assistance in gaining access 

to the Commission should contact the 

Office of the Secretary at (202) 205– 

2000. General information concerning 

the Commission may also be obtained 

by accessing its internet server at 

https://www.usitc.gov. The public 

record for this investigation may be 

viewed on the Commission’s electronic 

docket (EDIS) at https://edis.usitc.gov. 

FOR FURTHER INFORMATION CONTACT: The 

Office of Docket Services, U.S. 

International Trade Commission, 

telephone (202) 205–1802. 

SUPPLEMENTARY INFORMATION: 

Authority: The authority for 

institution of this investigation is 

contained in section 337 of the Tariff 

Act of 1930, as amended, 19 U.S.C. 1337 

and in section 210.10 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10 (2017). 

Scope of Investigation: Having 

considered the complaint, the U.S. 

International Trade Commission, on 

October 24, 2017, ordered that— 

(1) Pursuant to subsection (b) of 

section 337 of the Tariff Act of 1930, as 

amended, an investigation be instituted 

to determine whether there is a 

violation of subsection (a)(1)(B) of 

section 337 in the importation into the 

United States, the sale for importation, 

or the sale within the United States after 

importation of certain shaving 

cartridges, components thereof and 

products containing same by reason of 

infringement of one or more of claims 

1–4, 11–14, and 18–20 of the ’077 

patent, and whether an industry in the 

United States exists as required by 

subsection (a)(2) of section 337; 

(2) For the purpose of the 

investigation so instituted, the following 

are hereby named as parties upon which 

this notice of investigation shall be 

served: 

(a) The complainant is: The Gillette 

Company LLC, 1 Gillette Park, Boston, 

MA 02127. 

(b) The respondents are the following 

entities alleged to be in violation of 

section 337, and are the parties upon 

which the complaint is to be served: 

Edgewell Personal Care Company, 1350 

Timberlake Manor Parkway, 

Chesterfield, MO 63017; Edgewell 

Personal Care Brands, LLC, 6 Research 

Drive, Shelton, CT 06484; Edgewell 

Personal Care, LLC, 6 Research Drive, 

Shelton, CT 06484; Schick 

Manufacturing, Inc., 6 Research Drive, 

Shelton, CT 06484; Schick (Guangzhou) 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 208 / Monday, October 30, 2017 / Notices 50159 

Co., Limited, No. 3 Xia Yuan Road, 

Dong Ji, Industrial District, Getdd, 

Guangzhou 510730, China. 

(3) For the investigation so instituted, 

the Chief Administrative Law Judge, 

U.S. International Trade Commission, 

shall designate the presiding 

Administrative Law Judge. 

The Office of Unfair Import 

Investigations will not participate as a 

party in the investigation. 

The Commission notes that issues 

regarding whether the importation 

requirement of section 337 is met may 

be present here. In instituting this 

investigation, the Commission has not 

made any determination as to whether 

Complainant has satisfied this 

requirement. Accordingly, the presiding 

Administrative Law Judge may wish to 

consider this issue at an early date. 

Notwithstanding any Commission Rules 

to the contrary, which are hereby 

waived, any such decision should be 

issued in the form of an initial 

determination (ID) under Rule 210.42(c), 

19 CFR 210.42(c). The ID will become 

the Commission’s final determination 

45 days after the date of service of the 

ID unless the Commission determines to 

review the ID. Any such review will be 

conducted in accordance with 

Commission Rules 210.43, 210.44, and 

210.45, 19 CFR 210.43, 210.44, and 

210.45. 

Responses to the complaint and the 

notice of investigation must be 

submitted by the named respondents in 

accordance with section 210.13 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.13. Pursuant to 

19 CFR 201.16(e) and 210.13(a), such 

responses will be considered by the 

Commission if received not later than 20 

days after the date of service by the 

Commission of the complaint and the 

notice of investigation. Extensions of 

time for submitting responses to the 

complaint and the notice of 

investigation will not be granted unless 

good cause therefor is shown. 

Failure of a respondent to file a timely 

response to each allegation in the 

complaint and in this notice may be 

deemed to constitute a waiver of the 

right to appear and contest the 

allegations of the complaint and this 

notice, and to authorize the 

administrative law judge and the 

Commission, without further notice to 

the respondent, to find the facts to be as 

alleged in the complaint and this notice 

and to enter an initial determination 

and a final determination containing 

such findings, and may result in the 

issuance of an exclusion order or a cease 

and desist order or both directed against 

the respondent. 

By order of the Commission. 

Issued: October 25, 2017. 

Lisa R. Barton, 

Secretary to the Commission. 

[FR Doc. 2017–23542 Filed 10–27–17; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: Euticals Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before December 29, 2017. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Comments and requests for 

hearings on applications to import raw 

material are not appropriate. 72 FR 3417 

(January 25, 2007). 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on June 

20, 2017, Euticals, Inc., 2460 W. Bennett 

Street, Springfield, Missouri 65807– 

1229 applied to be registered as a bulk 

manufacturer the following basic classes 

of controlled substances: 

Controlled substance Drug code Schedule 

Gamma Hydroxybutyric Acid ........................................................................................................................................... 2010 I 

Amphetamine ................................................................................................................................................................... 1100 II 

Lisdexamfetamine ............................................................................................................................................................ 1205 II 

Methylphenidate .............................................................................................................................................................. 1724 II 

Phenylacetone ................................................................................................................................................................. 8501 II 

Methadone ....................................................................................................................................................................... 9250 II 

Methadone intermediate .................................................................................................................................................. 9254 II 

Tapentadol ....................................................................................................................................................................... 9780 II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution and sale to its 

customers. 

Dated: October 17, 2017. 

Demetra Ashley, 

Acting Assistant Administrator. 

[FR Doc. 2017–23556 Filed 10–27–17; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1110–0049] 

Agency Information Collection 

Activities; Proposed eCollection; 

eComments Requested InfraGard 

Membership Application and Profile 

AGENCY: Federal Bureau of 

Investigation, Department of Justice. 

ACTION: 30-day notice. 

SUMMARY: Department of Justice (DOJ), 

Federal Bureau of Investigation (FBI), 

Training Division’s Curriculum 

Management Section (CMS) will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

This proposed information collection 

was previously published in the Federal 

Register, on August 3, 2017 allowing for 

a 60 day comment period. 


sradovich on DSK3GMQ082PROD with NOTICES